Related Experiment Video

Updated: Jul 14, 2026

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas
09:21

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas

Published on: September 13, 2019

Multimodal therapy for the initial management of genital embryonal rhabdomyosarcoma in childhood

N R Maharaj1, D Nimako, G P Hadley

  • 1Department of Obstetrics and Gynaecology, Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa. maharajn13@ukzn.ac.za

International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|May 22, 2007
PubMed

Insights

Rhabdomyosarcoma, a common childhood cancer, is treated with a multimodal approach. This strategy combines surgery, chemotherapy, and radiotherapy for better outcomes in young patients.

Area of Science:

  • Pediatric Oncology
  • Surgical Pathology

Background:

  • Rhabdomyosarcoma is the most frequent soft tissue sarcoma in children.
  • Sarcoma botryoides, an embryonal rhabdomyosarcoma subtype, affects young girls, often presenting as a vaginal polypoid mass.

Observation:

  • Historically, treatment involved radical surgery.
  • Current management trends towards conservative surgery combined with chemotherapy and radiotherapy.

Findings:

  • The multimodal approach has improved survival rates.
  • This strategy aids in preserving normal anatomy and function.

Implications:

  • This approach offers a better quality of life for pediatric patients.
  • It highlights the importance of tailored, multidisciplinary treatment plans for rhabdomyosarcoma.

More Related Videos

Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model13:41

Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model

Published on: January 13, 2023

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...